Literature DB >> 22189524

Management of osteoarticular infections caused by Staphylococcus aureus is similar to that of other etiologies: analysis of 199 staphylococcal bone and joint infections.

Markus Pääkkönen1, Pentti E Kallio, Markku J T Kallio, Heikki Peltola.   

Abstract

BACKGROUND: Acute hematogenous osteomyelitis, septic arthritis, and their combination are considered to warrant especially aggressive treatment if caused by Staphylococcus aureus.
METHODS: Our prospective treatment trial of children aged 3 months to 15 years included 199 cases of S. aureus osteomyelitis, septic arthritis, or their combination. These cases were compared with 66 cases caused by other agents, mainly Haemophilus influenzae type b, Streptococcus pneumoniae, or Streptococcus pyogenes. According to protocol, the treatment was initiated intravenously only for 2 to 4 days and completed orally. Nonstaphylococcal and staphylococcal infections were treated similarly. Primary antibiotics were clindamycin or a first-generation cephalosporin. Follow-up lasted ≥ 12 months posthospitalization.
RESULTS: Staphylococcal infections did not significantly differ in the duration of medication, hospital stay, surgery performed, or the number of sequelae when compared with the other etiologic groups. One child with S. aureus arthritis developed 2 late infections by other agents in the same anatomic site. Except 3 mild sequelae (2 caused by S. aureus and 1 by S. pyogenes) 12 months posthospitalization, all patients recovered completely.
CONCLUSIONS: Osteoarticular infections of childhood caused by methicillin-susceptible S. aureus can be treated according to the same protocol as those used for infections caused by other agents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22189524     DOI: 10.1097/INF.0b013e31824657dd

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

Review 1.  Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskokovic
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2015       Impact factor: 4.889

2.  Repeated serum alkaline phosphatase measurements in the treatment of childhood acute bone and joint infections with high doses of antibiotics.

Authors:  Markus Pääkkönen; Markku J T Kallio; Pentti E Kallio; Heikki Peltola
Journal:  Ann Lab Med       Date:  2013-08-08       Impact factor: 3.464

3.  [99mTc]-labelled interleukin-8 as a diagnostic tool compared to [18F]FDG and CT in an experimental porcine osteomyelitis model.

Authors:  Pia Afzelius; Peter Mikael Helweg Heegaard; Svend Borup Jensen; Aage Kristian Olsen Alstrup; Henrik Carl Schønheyder; Annemarie Eek; Otto Boerman; Ole Lerberg Nielsen
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-02-25

4.  Epidemiology and Management of Acute Haematogenous Osteomyelitis in a Tertiary Paediatric Center.

Authors:  Elena Chiappini; Caterina Camposampiero; Simone Lazzeri; Giuseppe Indolfi; Maurizio De Martino; Luisa Galli
Journal:  Int J Environ Res Public Health       Date:  2017-05-04       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.